We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 21, 2022

Biomarkers of Retinal Hemangioblastoma in Patients With Von Hippel–Lindau Disease



Additional Info

Retinal Glial Cells in Von Hippel-Lindau Disease: A Novel Approach in the Pathophysiology of Retinal Hemangioblastoma
Cancers (Basel) 2021 Dec 30;[EPub Ahead of Print], E Pilotto, G Midena, T Torresin, G De Mojà, ML Bacelle, AM Ferrara, S Zovato, E Midena

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading